[1] 江登丰,乳糜泻研究进展. 胃肠病学和肝病学杂志,2010,19:478-481.
[2] Ludvigsson J F,Rubio-Tapia A,Van Dyke C T,et al. Increasing incidence of celiac disease in a North American population.Am J Gastroenterol,2013,108(5):818-824.
[3] Cataldo F,Montalto G.Celiac disease in the developing countries:a new and challenging public health problem. World J Gastroenterol,2007,13(15):2153-2159.
[4] 王歆琼,刘伟,徐俊杰,等.乳糜泻在中国慢性腹泻患儿中的发病情况.中华儿科杂志,2010,48:244-248.
[5] 王红玲,罗琳洁,寇继光,等. 中国湖北地区腹泻型肠易激综合征患者中成人乳糜泻血清学筛查. 中华内科杂志,2013,52(1):38-41.
[6] Vazquez-Roque MI,Camilleri M,Carlson P,et al.HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol,2011,23:481-487.
[7] Nehra V,Angulo P,Buchman AL,et al.Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci,2001,46:2347-2352.
[8] Bakhshipour A,Kaykhaei MA,Moulaei N,et al.Prevalence of coeliac disease in patients with non-alcoholic fatty liver disease. Arab J Gastroenterol,2013,14:113-115.
[9] Reilly NR,Lebwohl B,Hultcrantz R,et al.Increased risk of non alcoholic fatty liver disease after diagnosis of celiac disease. J Hepatol,2015,62:1405-1411.
[10] Rubio-Tapia A,Hill ID,Kelly CP,et al.ACG clinical guidelines:diagnosis and management of celiac disease. Am J Gastroenterol,2013,108:656-676.
[11] Alberto RT,Joseph AM.Classification and management of refractory celiac disease. Gut,2010,59:547-557.
[12] Malamut G,Murray JA,Cellier C.Refractory celiac disease. Gastro intest Endosc Clin N Am,2012,22:759-772.
[13] Simpson S,Thompson T.Nutrition assessment in celiac disease. Gastro intest Endosc Clin N Am,2012,22:797-809.
[14] 李融融,于康. 全程营养管理改善乳糜泻患者结局.协和医学杂志,2015,6(4):255.
[15] Gottlieb K,Dawson J,Hussain F,et al.Development of drugs for celiac disease:review of endpoints for Phase 2 and 3 trials. Gastroenterol Rep(Oxf),2015,3(2):91-102. |
